These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36672628)

  • 21. Exacerbated AIDS Progression by PD-1 Blockade during Therapeutic Vaccination in Chronically Simian Immunodeficiency Virus-Infected Rhesus Macaques after Interruption of Antiretroviral Therapy.
    Wu C; He Y; Zhao J; Luo K; Wen Z; Zhang Y; Li M; Cui Y; Liu Z; Wang C; Han Z; Li G; Feng F; Li P; Chen L; Sun C
    J Virol; 2022 Feb; 96(3):e0178521. PubMed ID: 34818070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling HIV-1 Latency Using Primary CD4
    Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.
    Rochat MA; Schlaepfer E; Speck RF
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+ T cells in people living with HIV.
    Calvet-Mirabent M; Sánchez-Cerrillo I; Martín-Cófreces N; Martínez-Fleta P; de la Fuente H; Tsukalov I; Delgado-Arévalo C; Calzada MJ; de Los Santos I; Sanz J; García-Fraile L; Sánchez-Madrid F; Alfranca A; Muñoz-Fernández MÁ; Buzón MJ; Martín-Gayo E
    EBioMedicine; 2022 Jul; 81():104090. PubMed ID: 35665682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cells are attracted to latent HIV-1-infected cells and enable virus reactivation via a non-canonical PI3K-NFκB signaling pathway.
    Chandra PK; Gerlach SL; Wu C; Khurana N; Swientoniewski LT; Abdel-Mageed AB; Li J; Braun SE; Mondal D
    Sci Rep; 2018 Oct; 8(1):14702. PubMed ID: 30279437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.
    Spina CA; Anderson J; Archin NM; Bosque A; Chan J; Famiglietti M; Greene WC; Kashuba A; Lewin SR; Margolis DM; Mau M; Ruelas D; Saleh S; Shirakawa K; Siliciano RF; Singhania A; Soto PC; Terry VH; Verdin E; Woelk C; Wooden S; Xing S; Planelles V
    PLoS Pathog; 2013; 9(12):e1003834. PubMed ID: 24385908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma Extracellular Vesicles Enhance HIV-1 Infection of Activated CD4
    Okoye I; Xu L; Oyegbami O; Shahbaz S; Pink D; Gao P; Sun X; Elahi S
    Front Immunol; 2021; 12():697604. PubMed ID: 34249000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
    Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.
    Lassen KG; Hebbeler AM; Bhattacharyya D; Lobritz MA; Greene WC
    PLoS One; 2012; 7(1):e30176. PubMed ID: 22291913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.
    Kristoff J; Palma ML; Garcia-Bates TM; Shen C; Sluis-Cremer N; Gupta P; Rinaldo CR; Mailliard RB
    EBioMedicine; 2019 May; 43():295-306. PubMed ID: 30952614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation.
    Abdel-Mohsen M; Chavez L; Tandon R; Chew GM; Deng X; Danesh A; Keating S; Lanteri M; Samuels ML; Hoh R; Sacha JB; Norris PJ; Niki T; Shikuma CM; Hirashima M; Deeks SG; Ndhlovu LC; Pillai SK
    PLoS Pathog; 2016 Jun; 12(6):e1005677. PubMed ID: 27253379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain macrophages harbor latent, infectious simian immunodeficiency virus.
    Abreu C; Shirk EN; Queen SE; Beck SE; Mangus LM; Pate KAM; Mankowski JL; Gama L; Clements JE
    AIDS; 2019 Dec; 33 Suppl 2(Suppl 2):S181-S188. PubMed ID: 31789817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infectious Virus Persists in CD4
    Abreu CM; Veenhuis RT; Avalos CR; Graham S; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Clements JE; Gama L
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31118264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCL6 Inhibitor-Mediated Downregulation of Phosphorylated SAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation.
    Cai Y; Abdel-Mohsen M; Tomescu C; Xue F; Wu G; Howell BJ; Ai Y; Sun J; Azzoni L; Le Coz C; Romberg N; Montaner LJ
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between Measures of HIV Reactivation and Decline of the Latent Reservoir under Latency-Reversing Agents.
    Petravic J; Rasmussen TA; Lewin SR; Kent SJ; Davenport MP
    J Virol; 2017 May; 91(9):. PubMed ID: 28202759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy.
    Prebensen C; Lind A; Dyrhol-Riise AM; Kvale D
    PLoS One; 2016; 11(4):e0153849. PubMed ID: 27128502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.
    Reuse S; Calao M; Kabeya K; Guiguen A; Gatot JS; Quivy V; Vanhulle C; Lamine A; Vaira D; Demonte D; Martinelli V; Veithen E; Cherrier T; Avettand V; Poutrel S; Piette J; de Launoit Y; Moutschen M; Burny A; Rouzioux C; De Wit S; Herbein G; Rohr O; Collette Y; Lambotte O; Clumeck N; Van Lint C
    PLoS One; 2009 Jun; 4(6):e6093. PubMed ID: 19564922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short communication: HIV antigen-specific reactivation of HIV infection from cellular reservoirs: implications in the settings of therapeutic vaccinations.
    Shete A; Thakar M; Singh DP; Gangakhedkar R; Gaikwad A; Pawar J; Paranjape R
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):835-43. PubMed ID: 21936714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone deacetylase inhibitor chidamide promotes reactivation of latent human immunodeficiency virus by introducing histone acetylation.
    Kuai Q; Lu X; Qiao Z; Wang R; Wang Y; Ye S; He M; Wang Y; Zhang T; Wu H; Ren S; Yu Q
    J Med Virol; 2018 Sep; 90(9):1478-1485. PubMed ID: 29704439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.